|
Index of reports
> All cases (147)
> Cases with Weight Decreased (12)
Below is the selection of adverse event reports related to Amaryl (Glimepiride) that includes all cases where reactions include weight decreased.
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-07-03
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-06-06
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Blood Sodium Increased, Oedema, Platelet Count Decreased, Muscle Spasms
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in 55 year old female receiving Amaryl (Glimepiride)
Reported by a consumer/non-health professional from United States on 2007-05-30
Patient: 55 year old female
Adverse reactions / side effects: Weight Decreased, Injection Site Haemorrhage, Somnolence, Tremor, Blood Glucose Decreased, Diarrhoea, Dizziness, Asthenia, Feeling Abnormal, Blood Glucose Increased
Suspect drug(s):
Amaryl
Dosage: see image
Administration route: Oral
End date: 2007-01-01
Amaryl
Dosage: see image
Administration route: Oral
Start date: 2003-01-01
Amaryl
Dosage: see image
Administration route: Oral
Start date: 2007-01-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2007-02-03
End date: 2007-03-04
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2007-03-05
Adverse event in 60 year old female receiving Amaryl (Glimepiride)
Reported by a consumer/non-health professional from United States on 2007-05-30
Patient: 60 year old female, weighing 85.3 kg (187.6 pounds)
Adverse reactions / side effects: Weight Decreased, Blood Glucose Decreased, Injection Site Erythema, Injection Site Pain, Injection Site Bruising, Tremor
Suspect drug(s):
Amaryl
Dosage: 3 mg; qd; po
Administration route: Oral
Indication: Diabetes Mellitus non-Insulin-Dependent
End date: 2006-11-24
Byetta
Dosage: 10 mcg; bid; sc, 5 mcg; bid; sc
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-11-20
End date: 2006-12-19
Byetta
Dosage: 10 mcg; bid; sc, 5 mcg; bid; sc
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-12-20
Other drugs received by patient: Aspirin
Adverse event in 59 year old female receiving Amaryl (Glimepiride)
Reported by a consumer/non-health professional from United States on 2007-05-30
Patient: 59 year old female, weighing 99.8 kg (219.5 pounds)
Adverse reactions / side effects: Weight Decreased, Nausea, Injection Site Bruising, Constipation, Tremor, Blood Glucose Decreased, Feeling Jittery, Energy Increased, Blood Glucose Increased, Decreased Appetite
Suspect drug(s):
Amaryl
Indication: Diabetes Mellitus non-Insulin-Dependent
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-01-01
End date: 2006-01-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-01-01
End date: 2006-01-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-01-01
End date: 2006-01-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-01-01
End date: 2006-01-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-06-01
End date: 2006-01-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-07-01
End date: 2006-01-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-09-01
End date: 2006-01-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-06-01
End date: 2006-08-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-08-19
End date: 2006-09-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2006-09-01
Byetta
Dosage: see image
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2007-01-01
Byetta
Byetta
Byetta
Pred Forte
Indication: Drug USE FOR Unknown Indication
Start date: 2006-12-20
End date: 2007-01-18
Other drugs received by patient: Amaryl
Adverse event in 77 year old female receiving Amaryl (Glimepiride)
Reported by a consumer/non-health professional from United States on 2007-05-30
Patient: 77 year old female
Adverse reactions / side effects: Blood Glucose Decreased, Weight Decreased, Drug Effect Decreased, Injection Site Extravasation, Injection Site Haemorrhage, Decreased Appetite
Suspect drug(s):
Amaryl
Dosage: 4 mg
Indication: Diabetes Mellitus non-Insulin-Dependent
Byetta
Dosage: 5 mcg;bid;sc
Indication: Diabetes Mellitus non-Insulin-Dependent
Start date: 2007-01-01
Other drugs received by patient: Glucophage XR; Actos
Adverse event in 69 year old female receiving Amaryl (Glimepiride)
Reported by a physician from Japan on 2007-05-23
Patient: 69 year old female, weighing 59.0 kg (129.8 pounds)
Adverse reactions / side effects: Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Weight Decreased, White Blood Cell Count Decreased, Blood Creatine Phosphokinase Increased, Alanine Aminotransferase Increased, Monocyte Count Increased, Muscle Twitching, Hypokalaemia, Blood Potassium Decreased, Aspartate Aminotransferase Increased, Oedema, Blood Sodium Increased, Platelet Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 1 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Diovan
Dosage: 80 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Fluitran
Dosage: 2 mg/day
Administration route: Oral
Indication: Oedema
End date: 2007-03-19
Glycyron
Dosage: 3 df/day
Administration route: Oral
Indication: Hepatic Cirrhosis
End date: 2007-03-19
Norvasc
Dosage: 5 mg/day
Administration route: Oral
Indication: Hypertension
End date: 2007-03-19
Norvasc
Start date: 2007-04-04
Other drugs received by patient: Aldactone
Adverse event in receiving Amaryl (Glimepiride)
Reported by a consumer/non-health professional from France on 2007-05-04
Patient:
Adverse reactions / side effects: Weight Decreased, Pruritus
Adverse event resulted in: hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Amaryl
Dosage: 2 mg, qd
Administration route: Oral
Cardensiel
Dosage: 10 mg, qd
Administration route: Oral
Lasilix / 00032601 /
Dosage: 60 mg, qd
Administration route: Oral
Previscan / 00789001 /
Dosage: unk, unk
Administration route: Oral
Tahor
Dosage: 10 mg, qd
Administration route: Oral
Adverse event in 73 year old female receiving Amaryl (Glimepiride)
Reported by a health professional (non-physician/pharmacist) from France on 2007-04-30
Patient: 73 year old female
Adverse reactions / side effects: Weight Decreased, Pruritus, Cardiac Pacemaker Insertion, Anorexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Cardensiel
Administration route: Oral
Lasix
Dosage: daily dose:60mg
Administration route: Oral
Previscan
Administration route: Oral
Tahor
Administration route: Oral
Triatec
Administration route: Oral
Adverse event in 73 year old female receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification from France on 2007-04-27
Patient: 73 year old female
Adverse reactions / side effects: Weight Decreased, Pruritus
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Dosage: 2 mg (2 mg, 1 d); oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Atorvastatin Calcium
Dosage: 10 mg (10 mg, 1 d); oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Bisoprolol Fumarate
Dosage: 10 mg (10 mg, 1 d); oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Lasix
Dosage: 1.5 dosage forms (1,5 dosage forms, 1 d); oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Previscan (20 MG, Tablet) (Fluindione)
Dosage: oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Ramipril
Dosage: 10 mg (5 mg, 2 in 1 d); oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 73 year old female receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification on 2007-04-26
Patient: 73 year old female
Adverse reactions / side effects: Weight Decreased, Pruritus
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Cardensiel
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Lasilix / 00032601 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Previscan / 00789001 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Tahor
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Triatec / 00885601 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 73 year old female receiving Amaryl (Glimepiride)
Reported by a individual with unspecified qualification on 2007-04-26
Patient: 73 year old female
Adverse reactions / side effects: Weight Decreased, Pruritus
Adverse event resulted in: hospitalization
Suspect drug(s):
Amaryl
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Cardensiel
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Lasilix / 00032601 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Previscan / 00789001 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Tahor
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Triatec / 00885601 /
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
|
